Marinus Pharmaceuticals Inc

NASDAQ:MRNS   3:59:27 PM EDT
16.17
+0.91 (+5.96%)
Officer Changes, Earnings Announcements

Marinus Pharmaceuticals Reports Quarterly Loss Per Share Of $0.55

Published: 03/09/2021 12:29 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results.
Marinus Pharmaceuticals Inc Says CFO Edward Smith, Will Be Leaving Company to Pursue Other Career Opportunities.
Marinus Pharmaceuticals Inc Says Steven Pfanstiel, Will Join Company As New Cfo.
Marinus Pharmaceuticals Inc Quarterly Loss per Share $0.55.
Revenue is expected to be $2.62 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $2.74 Million
Next Quarter EPS Guidance is expected to be -$0.50

More details on our Analysts Page.